{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_005734.5:c.91C>T (p.A30P)",
          "cDNA Change": {
            "transcript": "NM_005734.5",
            "ref": "C",
            "alt": "T",
            "position": "91"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_005734.5:c.160C>T (p.A53T)",
          "cDNA Change": {
            "transcript": "NM_005734.5",
            "ref": "C",
            "alt": "T",
            "position": "160"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        },
        {
          "HGVS": "NM_005734.5:c.138G>A (p.E46K)",
          "cDNA Change": {
            "transcript": "NM_005734.5",
            "ref": "G",
            "alt": "A",
            "position": "138"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004956"
  },
  "Experiment Method": [
    {
      "Assay Method": "Co-incubation and analysis of α-synuclein binding to synaptic membranes using brain cytosol",
      "Material used": {
        "Material Source": "Brain tissue",
        "Material Name": "Cytosolic extract from human brain tissue",
        "Description": "The study uses co-incubation of α-synuclein with or without brain cytosol and analyzes its binding to synaptic membranes."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_005734.5:c.91C>T (p.A30P)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired membrane binding",
          "Result Description": "A30P mutant α-synuclein exhibits impaired membrane binding compared to wild-type, which is mitigated by brain cytosol."
        },
        {
          "Variant": "NM_005734.5:c.160C>T (p.A53T)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired membrane binding",
          "Result Description": "A53T mutant α-synuclein exhibits impaired membrane binding compared to wild-type, which is mitigated by brain cytosol."
        },
        {
          "Variant": "NM_005734.5:c.138G>A (p.E46K)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired membrane binding",
          "Result Description": "E46K mutant α-synuclein exhibits impaired membrane binding compared to wild-type, which is mitigated by brain cytosol."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "The number of biological replicates is not explicitly stated in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "The number of technical replicates is not explicitly stated in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein is used as a positive control for membrane binding."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "The use of a negative control is not explicitly stated in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "The statistical analysis method is not explicitly stated in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal membrane binding activity of α-synuclein.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Impaired membrane binding activity of α-synuclein.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "The study uses a standard approach to analyze the binding properties of α-synuclein mutants, which is relevant for understanding their role in Parkinson's disease."
      }
    }
  ]
}